Health Care · Medical Care Facilities

Surgery Partners, Inc. SGRY

$15.90-0.51 (-3.11%)delayed quote · as of 2026-07-31 01:46 UTC

Open SGRY in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$2.1B

Previous close

$16.41

Volume

1.1M

52-week range

$11.41 – $24.10

Verdictconfidence 81% · high

Growing fast on a stretched balance sheet.

3 of 5 dimensions score well; health flashes caution. Momentum not scored — not enough data.

Value753/4 checks

Growth753/4 checks

Quality603/5 checks

Health402/5 checks

Momentum—0/2 checks

Fair-value estimate $20.25 per share (2-stage FCF · individual beta · 10Y Rf 4.7%) — the price sits 21% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

—

P/E FWD

23.8

EV/EBITDA TTM

9.8

PEG

—

FCF yield TTM

10.0%

Growth

Revenue 3y

+9.2%/yr

Revenue YoY

+6.2%

Expected EPS

—

Quality

Piotroski F

5 / 9

ROIC

487.0%

Gross margin

—

Health

Altman Z

0.75

Current ratio

1.87

Debt/equity

2.18

Momentum

vs 50-day

—

vs 200-day

—

52-wk range

35%

FY 2025: revenue $3.3B · net income -$77.9M · free cash flow $195.6M (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-31 01:46 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading SGRY’s filed statements…

Continue with SGRY in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.